Research progress on microRNA in gout

Jing Xie1, Cuixia He1,2, Yue Su1,3

  • 1Clinical Trials Center, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.

Frontiers in Pharmacology
|November 7, 2022
PubMed

Insights

MicroRNAs (miRNAs) regulate gout pathogenesis via cellular pathways. This review explores miRNA roles in gout, highlighting their potential as diagnostic biomarkers and therapeutic targets for this common arthritis.

Area of Science:

  • Rheumatology
  • Molecular Biology
  • Genetics

Background:

  • Gout is a prevalent inflammatory arthritis characterized by sodium urate crystal deposition in joints.
  • MicroRNAs (miRNAs) are key regulators of gene expression implicated in various diseases.
  • Emerging evidence suggests miRNAs play a significant role in gout pathogenesis.

Purpose of the Study:

  • To systematically review the regulatory functions of miRNAs in gout.
  • To identify potential miRNA-based therapeutic targets for gout treatment.
  • To evaluate the utility of miRNAs as diagnostic biomarkers for gout.

Main Methods:

  • Systematic literature review of studies investigating miRNA involvement in gout.
  • Analysis of cellular signaling pathways regulated by miRNAs in gout pathogenesis.
  • Compilation of current research on miRNA expression profiles in gout patients.

Main Results:

  • miRNAs significantly influence multiple cellular pathways critical to gout development.
  • Specific miRNAs have been identified as key players in the inflammatory response to urate crystals.
  • Dysregulated miRNA expression is associated with gout, suggesting their role in disease progression.

Conclusions:

  • MicroRNAs are crucial regulators in gout pathogenesis and represent promising therapeutic targets.
  • miRNAs hold potential as non-invasive biomarkers for early gout diagnosis and monitoring.
  • Further research into miRNA mechanisms can advance gout management strategies.